The pharma giant has invested in the clinical trial exploring the viability of Vedanta Biosciences’ VE202 inflammatory bowel disease treatment candidate.
in-PharmaTechnologist.com presents its latest round up of executive moves in the pharma sector, including appointments at Sanofi, Amylin, Lophius Biosciences, Lophius, Adventrx, BioSante and Medicure.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Discovery Laboratories, Eli Lilly and Agios Pharmaceuticals.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including changes at Relypsa, Genzyme, Benitec, Genmab, Celsion, Alligator Bioscience.
in-PharmaTechnologist presents its latest round up of movements in the sector, including appointments at Pfizer, Biocodex, Unigene, Pieris and Progenics.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Baxter, Dendreon, Roche, Somaxon and Silence Therapeutics.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including the retirement of Biogen Idec’s CEO and appointments at Dishman and Noven.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Novartis’ former CEO joining Amylin’s board and an appointment at OctoPlus.
LabTechnologist.com brings you its periodic round-up of industry
news with Inverness winning the bidding war for Biosite, Bio-Rad
agreeing to purchase DiaMed, and news from Ciphergen, Eksigent,
Siemens and Thermo Fisher Scientific.
LabTechnologist.com presents its periodic round up of recent
industry news with new developments at Beckman Coulter, Thermo
Fisher Scientific, Millipore, GE Healthcare and 454 Life Sciences.
LabTechnologist.com presents its periodic round up of recent
industry news with new developments at Agilent, Ciphergen,
Illumina, Inverness, PerkinElmer and Thermo Fisher Scientific.
According to a latest report, the growth of the biotechnology
company will continue to outpace that of pharmaceutical companies,
with the seven largest biotechnology companies growing at rates
faster than the pharmaceutical industry's...
